As new biosimilars enter the market, increased competition brings down the price of the biosimilar and reference product. As biosimilars continue to grow in use, it is important to understand what they are and their impact in the market.
In our ongoing efforts to ensure access to high quality, affordable health care and reduce costs, Excellus BlueCross BlueShield leads the insurance industry in pursuing biosimilar drugs for our members and have been a national leader in biosimilar adoption since their inception.
To learn more about our approach to biosimilars? Read our blog, “Preparing for the Biosimilar Landscape”.
Read “Preparing for the Biosimilar Landscape”
